» Articles » PMID: 19292457

Cholesterol Exposure at the Membrane Surface is Necessary and Sufficient to Trigger Perfringolysin O Binding

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2009 Mar 19
PMID 19292457
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Perfringolysin O (PFO) is the prototype for the cholesterol-dependent cytolysins, a family of bacterial pore-forming toxins that act on eukaryotic membranes. The pore-forming mechanism of PFO exhibits an absolute requirement for membrane cholesterol, but the complex interplay between the structural arrangement of the PFO C-terminal domain and the distribution of cholesterol in the target membrane is poorly understood. Herein we show that PFO binding to the bilayer and the initiation of the sequence of events that culminate in the formation of a transmembrane pore depend on the availability of free cholesterol at the membrane surface, while changes in the acyl chain packing of the phospholipids and cholesterol in the membrane core, or the presence or absence of detergent-resistant domains do not correlate with PFO binding. Moreover, PFO association with the membrane was inhibited by the addition of sphingomyelin, a typical component of membrane rafts in cell membranes. Finally, addition of molecules that do not interact with PFO, but intercalate into the membrane and displace cholesterol from its association with phospholipids (e.g., epicholesterol), reduced the amount of cholesterol required to trigger PFO binding. Taken together, our studies reveal that PFO binding to membranes is triggered when the concentration of cholesterol exceeds the association capacity of the phospholipids, and this cholesterol excess is then free to associate with the toxin.

Citing Articles

Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae.

Watt E, Andriescu I, Ho E Drug Deliv Transl Res. 2024; .

PMID: 39285123 DOI: 10.1007/s13346-024-01708-5.


Distant relatives of a eukaryotic cell-specific toxin family evolved a complement-like mechanism to kill bacteria.

Abrahamsen H, Sanford T, Collamore C, Johnstone B, Coyne M, Garcia-Bayona L Nat Commun. 2024; 15(1):5028.

PMID: 38866748 PMC: 11169675. DOI: 10.1038/s41467-024-49103-5.


Structural basis for the unique molecular properties of broad-range phospholipase C from Listeria monocytogenes.

Petrisic N, Adamek M, Kezar A, Hocevar S, Zagar E, Anderluh G Nat Commun. 2023; 14(1):6474.

PMID: 37838694 PMC: 10576769. DOI: 10.1038/s41467-023-42134-4.


The Inseparable Relationship Between Cholesterol and Hedgehog Signaling.

Siebold C, Rohatgi R Annu Rev Biochem. 2023; 92:273-298.

PMID: 37001135 PMC: 10330520. DOI: 10.1146/annurev-biochem-052521-040313.


A basic model for the association of ligands with membrane cholesterol: application to cytolysin binding.

Lange Y, Tabei S, Steck T J Lipid Res. 2023; 64(4):100344.

PMID: 36791915 PMC: 10119614. DOI: 10.1016/j.jlr.2023.100344.


References
1.
Soltani C, Hotze E, Johnson A, Tweten R . Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin. J Biol Chem. 2007; 282(21):15709-16. PMC: 3746338. DOI: 10.1074/jbc.M701173200. View

2.
Ramachandran R, Heuck A, Tweten R, Johnson A . Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat Struct Biol. 2002; 9(11):823-7. DOI: 10.1038/nsb855. View

3.
London E, Brown D . Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta. 2000; 1508(1-2):182-95. DOI: 10.1016/s0304-4157(00)00007-1. View

4.
Nelson L, Johnson A, London E . How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction. J Biol Chem. 2007; 283(8):4632-42. DOI: 10.1074/jbc.M709483200. View

5.
Tilley S, Orlova E, Gilbert R, Andrew P, Saibil H . Structural basis of pore formation by the bacterial toxin pneumolysin. Cell. 2005; 121(2):247-56. DOI: 10.1016/j.cell.2005.02.033. View